GSTM1 and cold agglutinin disease: ,11 In both studies, treatment with sutimlimab rapidly inhibited activity of the classical complement pathway, halted haemolysis, increased haemoglobin (Hb) levels, and reduced fatigue in patients with CAD, regardless of recent transfusion history.